These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Antibiotic sensitivity of Vibrio cholerae 01, isolated in the Ukraine in 1994]. Khaĭtovich AB; Ved'mina EA; Shenderovich VA; Vlasova IV Antibiot Khimioter; 1996 Jun; 41(6):25-8. PubMed ID: 9054324 [TBL] [Abstract][Full Text] [Related]
4. [The properties of the Vibrio cholerae strains isolated in large districts in western Dagestan in 1994]. Cherepakhina IIa; Lomov IuM; Karagozova AV; Pomukhina OI; Smolikova LM; Makedonova LD; Dimitrova NI; Nekliaev VN; Balakhnova VV; Chirkova OO Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():84-6. PubMed ID: 7771155 [TBL] [Abstract][Full Text] [Related]
5. [Antibacterial susceptibility/resistance of Vibrio cholerae eltor clinical strains isolated in the Caucasus during the seventh cholera pandemic]. Savel'ev VN; Babenyshev BV; Savel'eva IV; Vasil'eva OV; Guseva LV; Grizhebovskiĭ GM; Kurbanov ShKh; Asvarov BM; Batyrova BA; Doroshenko IG; Antonenko AD Antibiot Khimioter; 2010; 55(5-6):8-13. PubMed ID: 21033468 [TBL] [Abstract][Full Text] [Related]
6. [Microtest systems in the diagnosis of cholera]. Abdullaeva ZG; Medzhidov MM Klin Lab Diagn; 2003 Feb; (2):48-9. PubMed ID: 12688218 [TBL] [Abstract][Full Text] [Related]
7. Tetracycline resistant cholera in Kelantan. Ranjit K; Nurahan M Med J Malaysia; 2000 Mar; 55(1):143-5. PubMed ID: 11072502 [TBL] [Abstract][Full Text] [Related]
8. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. Dengo-Baloi LC; Semá-Baltazar CA; Manhique LV; Chitio JE; Inguane DL; Langa JP PLoS One; 2017; 12(8):e0181496. PubMed ID: 28792540 [TBL] [Abstract][Full Text] [Related]
9. Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta. Ramamurthy T; Pal A; Bhattacharya MK; Bhattacharya SK; Chowdhury AS; Takeda Y; Takeda T; Pal SC; Nair GB Indian J Med Res; 1992 May; 95():125-9. PubMed ID: 1506061 [TBL] [Abstract][Full Text] [Related]
10. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Garg P; Chakraborty S; Basu I; Datta S; Rajendran K; Bhattacharya T; Yamasaki S; Bhattacharya SK; Takeda Y; Nair GB; Ramamurthy T Epidemiol Infect; 2000 Jun; 124(3):393-9. PubMed ID: 10982062 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008. Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810 [TBL] [Abstract][Full Text] [Related]
12. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139. Khan WA; Bennish ML; Seas C; Khan EH; Ronan A; Dhar U; Busch W; Salam MA Lancet; 1996 Aug; 348(9023):296-300. PubMed ID: 8709688 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. Chakrabarti MK; Bhattacharya MK; Bhattacharya J; Bhattacharya SK; Mahalanabis D Chemotherapy; 1998; 44(2):108-11. PubMed ID: 9551241 [TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis on the epidemiology of antibiotic resistance of Vibrio cholerae in Iran. Yousefi A; Vaez H; Sahebkar A; Khademi F Ann Ig; 2019; 31(3):279-290. PubMed ID: 31069372 [TBL] [Abstract][Full Text] [Related]
16. [Vibrio cholerae strains resistant to vibriostatic factor 0/129 isolated from a patient with cholera in Poland]. Stypułkowska-Misiurewicz H; Gardocka H; Sieczka Z Med Dosw Mikrobiol; 1994; 46(4):313-21. PubMed ID: 7603133 [TBL] [Abstract][Full Text] [Related]
17. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection. Dhar U; Bennish ML; Khan WA; Seas C; Huq Khan E; Albert MJ; Abdus Salam M Trans R Soc Trop Med Hyg; 1996; 90(4):402-5. PubMed ID: 8882188 [TBL] [Abstract][Full Text] [Related]
18. [Characteristics of the cholera epidemic of 1998 in Ecuador during El Niño]. Gabastou JM; Pesantes C; Escalante S; Narváez Y; Vela E; García L; Zabala D; Yadon ZE Rev Panam Salud Publica; 2002 Sep; 12(3):157-64. PubMed ID: 12396633 [TBL] [Abstract][Full Text] [Related]
19. [Bacteriologic data on Vibrio cholerae strains isolated in Senegal]. Castets M; Sarrat H; Mora M Bull Soc Med Afr Noire Lang Fr; 1972; 17(4):631-5. PubMed ID: 4666268 [No Abstract] [Full Text] [Related]
20. [Comparative evaluation of activity of antibacterial agents in vitro and their efficacy in experimental cholera due to strains of Vibrio cholerae O1 and O139 serogroups in albino mice]. Dudina NA; Shut'ko AG; Ryzhko IV; Tsuraeva RI; Moldavan IA Antibiot Khimioter; 2004; 49(11):23-7. PubMed ID: 15945546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]